Baicalein ameliorates Alzheimer's disease via orchestration of CX3CR1/NF-κB pathway in a triple transgenic mouse model.

[1]  G. Landreth,et al.  CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease , 2022, Molecular Neurodegeneration.

[2]  Ming-Chung Lee,et al.  Baicalein Exerts Therapeutic Effects against Endotoxin-Induced Depression-like Behavior in Mice by Decreasing Inflammatory Cytokines and Increasing Brain-Derived Neurotrophic Factor Levels , 2022, Antioxidants.

[3]  Bailiu Ya,et al.  Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target , 2021, Frontiers in Aging Neuroscience.

[4]  P. Matthews,et al.  Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology , 2021, bioRxiv.

[5]  E. Richard,et al.  Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  B. Albensi,et al.  Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia , 2021, International journal of molecular sciences.

[7]  J. Mulder,et al.  Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease , 2021, Acta Neuropathologica.

[8]  Yuanyuan Deng,et al.  Isorhynchophylline Ameliorates Cerebral Ischemia/Reperfusion Injury by Inhibiting CX3CR1-Mediated Microglial Activation and Neuroinflammation , 2021, Frontiers in Pharmacology.

[9]  Z. Jing,et al.  DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension , 2020, Science Advances.

[10]  Wei Li,et al.  Candesartan modulates microglia activation and polarization via NF-κB signaling pathway , 2020, International journal of immunopathology and pharmacology.

[11]  Dong Hyun Kim,et al.  Neuroprotective Effects of Baicalein, Wogonin, and Oroxylin A on Amyloid Beta-Induced Toxicity via NF-κB/MAPK Pathway Modulation , 2020, Molecules.

[12]  Ukpong B. Eyo,et al.  Negative feedback control of neuronal activity by microglia , 2020, Nature.

[13]  M. Xiao,et al.  Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/Caspase-1/GSDMD Pathway in MPTP-Induced Mice Model of Parkinson’s Disease , 2020, The international journal of neuropsychopharmacology.

[14]  J. Leza,et al.  Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline , 2020, Glia.

[15]  E. Kavanagh,et al.  Microglia: Agents of the CNS Pro-Inflammatory Response , 2020, Cells.

[16]  Y. Mao,et al.  Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension , 2020, European Respiratory Journal.

[17]  Christopher J. Bohlen,et al.  Microglia in Brain Development, Homeostasis, and Neurodegeneration. , 2019, Annual review of genetics.

[18]  S. Hickman,et al.  Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice , 2019, Front. Immunol..

[19]  G. B. Frisoni,et al.  Current and emerging avenues for Alzheimer's disease drug targets , 2019, Journal of internal medicine.

[20]  T. Wyss-Coray,et al.  Lipid droplet accumulating microglia represent a dysfunctional and pro-inflammatory state in the aging brain , 2019, bioRxiv.

[21]  M. Blurton-Jones,et al.  Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk. , 2019, Journal of molecular biology.

[22]  Xiaobin Pang,et al.  Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPAR&ggr;/Nrf2/NF‐&kgr;B signaling pathway , 2019, International immunopharmacology.

[23]  T. Deierborg,et al.  Bidirectional Microglia–Neuron Communication in Health and Disease , 2018, Front. Cell. Neurosci..

[24]  S. Hickman,et al.  Microglia in neurodegeneration , 2018, Nature Neuroscience.

[25]  K. Blennow,et al.  Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease , 2018, Alzheimer's Research & Therapy.

[26]  K. Blennow,et al.  Prevalence of preclinical Alzheimer disease , 2018, Neurology.

[27]  A. Chiò,et al.  Common polymorphisms of chemokine (C‐X3‐C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population‐based study , 2018, Muscle & nerve.

[28]  J. Ávila,et al.  Absence of microglial CX3CR1 impairs the synaptic integration of adult-born hippocampal granule neurons , 2018, Brain, Behavior, and Immunity.

[29]  E. Gelpí,et al.  Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer’s Disease , 2018, Molecular Neurobiology.

[30]  Liu Yang,et al.  Involvement of NF-κB and the CX3CR1 Signaling Network in Mechanical Allodynia Induced by Tetanic Sciatic Stimulation , 2018, Neuroscience Bulletin.

[31]  Anastasia G. Efthymiou,et al.  Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk , 2017, Molecular Neurodegeneration.

[32]  R. Banik,et al.  Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. , 2017, European journal of medicinal chemistry.

[33]  Jian-feng Lei,et al.  Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer’s Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET , 2016, International journal of molecular sciences.

[34]  I. Kurkowska-Jastrzębska,et al.  Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents , 2016, Molecular Neurobiology.

[35]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[36]  L. Pan,et al.  Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice , 2016, International journal of molecular medicine.

[37]  Y. Nakagawa,et al.  Diversity and plasticity of microglial cells in psychiatric and neurological disorders. , 2015, Pharmacology & therapeutics.

[38]  Zhengtao Yang,et al.  Baicalein attenuates inflammatory responses by suppressing TLR4 mediated NF-κB and MAPK signaling pathways in LPS-induced mastitis in mice. , 2015, International immunopharmacology.

[39]  D. Attwell,et al.  Receptors, Ion Channels, and Signaling Mechanisms Underlying Microglial Dynamics* , 2015, The Journal of Biological Chemistry.

[40]  L. Tan,et al.  Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. , 2015, Annals of translational medicine.

[41]  T. Wyss-Coray,et al.  Microglial dysfunction in brain aging and Alzheimer's disease. , 2014, Biochemical pharmacology.

[42]  H. Hou,et al.  Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model , 2013, Journal of neuroscience research.

[43]  R. Ransohoff,et al.  CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[44]  R. Ransohoff,et al.  CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. , 2010, The American journal of pathology.

[45]  Richard M. Page,et al.  Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease , 2010, Nature Neuroscience.

[46]  H. Neumann,et al.  Neuronal ‘On’ and ‘Off’ signals control microglia , 2007, Trends in Neurosciences.

[47]  R. Petersen,et al.  Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease , 2007 .

[48]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[49]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.